Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 6 de 6
1.
Sci Rep ; 8(1): 5488, 2018 04 03.
Article En | MEDLINE | ID: mdl-29615752

Indoleamine 2,3-dioxygenase-1 (IDO1) mediates the degradation of L-tryptophan (L-Trp) and is constitutively expressed in the chorionic vascular endothelium of the human placenta with highest levels in the microvasculature. Given that endothelial expression of IDO1 has been shown to regulate vascular tone and blood pressure in mice under the condition of systemic inflammation, we asked whether IDO1 is also involved in the regulation of placental blood flow and if yes, whether this function is potentially impaired in intrauterine growth restriction (IUGR) and pre-eclampsia (PE). In the large arteries of the chorionic plate L-Trp induced relaxation only after upregulation of IDO1 using interferon gamma and tumor necrosis factor alpha. However, ex vivo placental perfusion of pre-constricted cotyledonic vasculature with L-Trp decreases the vessel back pressure without prior IDO1 induction. Further to this finding, IDO1 protein expression and activity is reduced in IUGR and PE when compared to gestational age-matched control tissue. These data suggest that L-Trp catabolism plays a role in the regulation of placental vascular tone, a finding which is potentially linked to placental and fetal growth. In this context our data suggest that IDO1 deficiency is related to the pathogenesis of IUGR and PE.


Blood Vessels/physiopathology , Endothelium, Vascular/enzymology , Fetal Growth Retardation/enzymology , Placenta/blood supply , Pre-Eclampsia/enzymology , Adult , Arteries/physiopathology , Endothelium, Vascular/metabolism , Female , Fetal Growth Retardation/pathology , Fetal Growth Retardation/physiopathology , Gene Expression Regulation, Enzymologic , Humans , Pre-Eclampsia/pathology , Pre-Eclampsia/physiopathology , Pregnancy , Vasodilation
2.
Nanotoxicology ; 12(2): 90-103, 2018 03.
Article En | MEDLINE | ID: mdl-29334310

A thorough understanding of nanoparticle bio-distribution at the feto-maternal interface will be a prerequisite for their diagnostic or therapeutic application in women of childbearing age and for teratologic risk assessment. Therefore, the tissue interaction of biocompatible dendritic polyglycerol nanoparticles (dPG-NPs) with first- trimester human placental explants were analyzed and compared to less sophisticated trophoblast-cell based models. First-trimester human placental explants, BeWo cells and primary trophoblast cells from human term placenta were exposed to fluorescence labeled, ∼5 nm dPG-NPs, with differently charged surfaces, at concentrations of 1 µM and 10 nM, for 6 and 24 h. Accumulation of dPGs was visualized by fluorescence microscopy. To assess the impact of dPG-NP on trophoblast integrity and endocrine function, LDH, and hCG releases were measured. A dose- and charge-dependent accumulation of dPG-NPs was observed at the early placental barrier and in cell lines, with positive dPG-NP-surface causing deposits even in the mesenchymal core of the placental villi. No signs of plasma membrane damage could be detected. After 24 h we observed a significant reduction of hCG secretion in placental explants, without significant changes in trophoblast apoptosis, at low concentrations of charged dPG-NPs. In conclusion, dPG-NP's surface charge substantially influences their bio-distribution at the feto-maternal interface, with positive charge facilitating trans-trophoblast passage, and in contrast to more artificial models, the first-trimester placental explant culture model reveals potentially hazardous influences of charged dPG-NPs on early placental physiology.


Chorionic Gonadotropin/metabolism , Dendritic Cells/metabolism , Glycerol/pharmacology , Glycerol/pharmacokinetics , Nanoparticles/chemistry , Placenta/metabolism , Polymers/pharmacology , Polymers/pharmacokinetics , Apoptosis , Biological Availability , Cells, Cultured , Female , Glycerol/chemistry , Humans , Polymers/chemistry , Pregnancy , Pregnancy Trimester, First , Surface Properties , Trophoblasts/metabolism
3.
Reprod Biol ; 15(1): 65-8, 2015 Mar.
Article En | MEDLINE | ID: mdl-25726379

Endometrial morphology and expression of vascular endothelial growth factor (VEGF) was examined in the endometria of women with history of recurrent miscarriage (RM group) and of fertile women without history of gynecological diseases (control group). Luteal phase defect (LPD) was diagnosed in 42% cases in the RM group vs. 13% in controls. Endometrial VEGF mRNA expression was lower in LPD endometria compared to mature endometria. In conclusion, LPD in non-pregnant endometrium is associated with angiogenic abnormalities and may cause pregnancy complications.


Endometrium/metabolism , Gene Expression Regulation/physiology , Luteal Phase/physiology , RNA, Messenger/metabolism , Vascular Endothelial Growth Factor A/metabolism , Female , Humans , Pregnancy , RNA, Messenger/genetics , Vascular Endothelial Growth Factor A/genetics
5.
Reprod Toxicol ; 41: 73-9, 2013 Nov.
Article En | MEDLINE | ID: mdl-23751448

Next to nothing is known about nanoparticle and nanofiber trafficking at the feto-maternal interface in early human pregnancy. As the first trimester is thought to be crucial for the further placental and fetal development, it will be important to assess the possible risks of nanomaterial exposures during this period. There are some intriguing observations in nanotoxicology, however, indicating certain differences between classical toxicology and nanotoxicology. To understand nanomaterial-biokinetics and placental toxicity in early gestation, the special architecture, the hypoxic condition, the bilayer of villous trophoblast, the plugging of spiral arteries and the contribution of intrauterine glands to nutrition, as well as the delicate immunologic situation at the implantation site, will have to be considered. Unless nano-specific biokinetics are properly understood, it will be difficult to ensure identification of potential "nano-thalidomides" among all the newly engineered nanoparticles and fibers, based on the models available in reproductive toxicology.


Nanostructures/toxicity , Placenta/drug effects , Animals , Female , Humans , Maternal-Fetal Exchange , Pharmacokinetics , Placenta/anatomy & histology , Placenta/physiology , Pregnancy
6.
PLoS One ; 6(3): e15086, 2011 Mar 08.
Article En | MEDLINE | ID: mdl-21408197

The distribution of cells in stained tissue sections provides information that may be analyzed by means of morphometric computation. We developed an algorithm for automated analysis for the purpose of answering questions pertaining to the relative densities of wandering cells in the vicinity of comparatively immobile tissue structures such as vessels or tumors. As an example, we present the analysis of distribution of CD56-positive cells and of CXCR3-positive cells (relative densities of peri-vascular versus non-vascular cell populations) in relation to the endothelium of capillaries and venules of human parietal decidua tissue of first trimester pregnancy. In addition, the distribution of CD56-positive cells (mostly uterine NK cells) in relation to spiral arteries is analyzed. The image analysis is based on microphotographs of two-color immunohistological stainings. Discrete distances (10-50 µm) from the fixed structures were chosen for the purpose of defining the extent of neighborhood areas. For the sake of better comparison of cell distributions at different overall cell densities a model of random distribution of "cells" in relation to neighborhood areas and rest decidua of a specific sample was built. In the chosen instances, we found increased perivascular density of CD56-positive cells and of CXCR3-positive cells. In contrast, no accumulation of CD56-positive cells was found in the neighborhood of spiral arteries.


Cell Movement , Decidua/cytology , Immunohistochemistry/methods , Automation , Blood Vessels/metabolism , CD56 Antigen/metabolism , Computer Simulation , Decidua/metabolism , Endothelium/metabolism , Female , Humans , Imaging, Three-Dimensional , Pregnancy , Pregnancy Trimester, First/metabolism , Receptors, CXCR3/metabolism , Tissue Distribution
...